tiprankstipranks
Alaunos Therapeutics (TCRT)
NASDAQ:TCRT
US Market
TCRT
Alaunos Therapeutics
RESEARCH TOOLSreports
Want to see TCRT full AI Analyst Report?

Alaunos Therapeutics (TCRT) Income Statement

691 Followers

Alaunos Therapeutics Income Statement

Last quarter (Q4 2025), Alaunos Therapeutics's total revenue was $3.00K, a decrease of -25.00% from the same quarter last year. In Q4, Alaunos Therapeutics's net income was $-893.00K. See Alaunos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 5.00K$ 10.00K$ 5.00K$ 2.92M$ 398.00K
Gross Profit
$ 5.00K$ 10.00K$ -4.80M$ 2.92M$ 398.00K
Operating Expenses
$ 4.23M$ 4.82M$ 29.47M$ 38.03M$ 77.95M
Depreciation and Amortization
$ 7.00K$ 2.00K$ 2.31M$ 2.76M$ 2.60M
EBITDA
$ -4.22M$ -4.68M$ -30.90M$ -31.82M$ -74.97M
Operating Income
$ -4.22M$ -4.81M$ -34.27M$ -35.10M$ -77.55M
Other Income/Expenses
$ 49.00K$ 133.00K$ -873.00K$ -2.63M$ -1.20M
Pretax Income
$ -4.18M$ -4.68M$ -35.14M$ -37.73M$ -78.75M
Net Income
$ -4.18M$ -4.68M$ -35.14M$ -37.73M$ -78.75M
Per Share Metrics
Basic EPS
$ -2.20$ -2.92$ -21.97$ -25.97$ -53.80
Diluted EPS
$ -2.20$ -2.92$ -21.97$ -25.97$ -53.80
Weighted Average Shares Outstanding
 1.95M 1.60M 1.60M 1.45M 1.43M
Weighted Average Shares Outstanding (Diluted)
 1.95M 1.60M 1.60M 1.45M 1.43M
Currency in USD

Alaunos Therapeutics Earnings and Revenue History